A drug candidate developed by Sanofi and the Drugs for Neglected Diseases initiative (DNDi) has shown very high efficacy in treating sleeping sickness, a sometimes lethal condition that is endemic across Sub-Saharan Africa.
Source: Drug Industry Daily